157 related articles for article (PubMed ID: 15675522)
21. Safety and protective efficacy of intramuscular vaccination with a live aroA derivative of Pasteurella multocida B:2 against experimental hemorrhagic septicemia in calves.
Dagleish MP; Hodgson JC; Ataei S; Finucane A; Finlayson J; Sales J; Parton R; Coote JG
Infect Immun; 2007 Dec; 75(12):5837-44. PubMed ID: 17875632
[TBL] [Abstract][Full Text] [Related]
22. Protection, humoral and cell-mediated immune responses in calves immunized with multiple emulsion haemorrhagic septicaemia vaccine.
Verma R; Jaiswal TN
Vaccine; 1997 Aug; 15(11):1254-60. PubMed ID: 9286053
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of outer membrane protein of Pasteurella multocida in buffalo calves.
Pati US; Srivastava SK; Roy SC; More T
Vet Microbiol; 1996 Oct; 52(3-4):301-11. PubMed ID: 8972056
[TBL] [Abstract][Full Text] [Related]
24. Identification of immunogenic proteins associated with protection against haemorrhagic septicaemia after vaccination of calves with a live-attenuated aroA derivative of Pasteurella multocida B:2.
Ataei S; Burchmore R; Christopher Hodgson J; Finucane A; Parton R; Coote JG
Res Vet Sci; 2009 Oct; 87(2):207-10. PubMed ID: 19243798
[TBL] [Abstract][Full Text] [Related]
25. Field use of live haemorrhagic septicaemia vaccine.
Myint A; Carter GR
Vet Rec; 1990 Jun; 126(26):648. PubMed ID: 2116692
[No Abstract] [Full Text] [Related]
26. Binding of bovine transferrin by Pasteurella multocida serotype B:2,5, a strain which causes haemorrhagic septicaemia in buffalo and cattle.
Veken JW; Oudega B; Luirink J; de Graaf FK
FEMS Microbiol Lett; 1994 Jan; 115(2-3):253-7. PubMed ID: 8138137
[TBL] [Abstract][Full Text] [Related]
27. Interaction between Pasteurella multocida B:2 and its derivatives with bovine aortic endothelial cell (BAEC).
Kamal NM; Zamri-Saad M; Masarudin MJ; Othman S
BMC Vet Res; 2017 Jun; 13(1):186. PubMed ID: 28629460
[TBL] [Abstract][Full Text] [Related]
28. Haemorrhagic septicaemia vaccines.
Verma R; Jaiswal TN
Vaccine; 1998 Jul; 16(11-12):1184-92. PubMed ID: 9682378
[TBL] [Abstract][Full Text] [Related]
29. Serological evaluation of Pasteurella multocida antigens associated with protection in buffalo calves.
Afzal M; Muneer R; Akhtar S
Rev Sci Tech; 1992 Sep; 11(3):917-23. PubMed ID: 1472736
[TBL] [Abstract][Full Text] [Related]
30. Immune responses to haemorrhagic septicaemia (HS) vaccination in Trypanosoma evansi infected buffalo-calves.
Singla LD; Juyal PD; Sharma NS
Trop Anim Health Prod; 2010 Apr; 42(4):589-95. PubMed ID: 19784863
[TBL] [Abstract][Full Text] [Related]
31. Development of a PCR test based on a gene region associated with the pathogenicity of Pasteurella multocida serotype B:2, the causal agent of haemorrhagic septicaemia in Asia.
Brickell SK; Thomas LM; Long KA; Panaccio M; Widders PR
Vet Microbiol; 1998 Jan; 59(4):295-307. PubMed ID: 9556860
[TBL] [Abstract][Full Text] [Related]
32. Improved stability of live attenuated vaccine gdhA derivative Pasteurella multocida B:2 by freeze drying method for use as animal vaccine.
Oslan SNH; Halim M; Ramle NA; Saad MZ; Tan JS; Kapri MR; Ariff AB
Cryobiology; 2017 Dec; 79():1-8. PubMed ID: 29037980
[TBL] [Abstract][Full Text] [Related]
33. Cloning of 87 kDa outer membrane protein gene of Pasteurella multocida P52.
Chaudhuri P; Goswami PP
Res Vet Sci; 2001 Jun; 70(3):255-6. PubMed ID: 11676623
[TBL] [Abstract][Full Text] [Related]
34. Responses of pro-inflammatory cytokines, acute phase proteins and cytological analysis in serum and cerebrospinal fluid during haemorrhagic septicaemia infection in buffaloes.
Chung ELT; Jesse FFA; Marza AD; Ibrahim HH; Abba Y; Zamri-Saad M; Haron AW; Lila MAM; Saharee AA; Omar AR; Bakar MZA; Norsidin MJ
Trop Anim Health Prod; 2019 Jul; 51(6):1773-1782. PubMed ID: 30919320
[TBL] [Abstract][Full Text] [Related]
35. Comparative sequence analysis of 16S rRNA gene of Pasteurella multocida serogroup B isolates from different animal species.
Dey S; Singh VP; Kumar AA; Sharma B; Srivastava SK; Singh N
Res Vet Sci; 2007 Aug; 83(1):1-4. PubMed ID: 17459437
[TBL] [Abstract][Full Text] [Related]
36. Vacuolating cytotoxic activity of Pasteurella multocida causing haemorrhagic septicaemia in buffalo and cattle.
Shah NH; Biewenga J; Shah NH; de Graaf FK
FEMS Microbiol Lett; 1996 Sep; 143(1):97-101. PubMed ID: 8807808
[TBL] [Abstract][Full Text] [Related]
37. Protection of cattle against experimental haemorrhagic septicaemia by the capsular antigens of Pasteurella multocida, types B and E.
Nagy LK; Penn CW
Res Vet Sci; 1976 May; 20(3):249-53. PubMed ID: 59379
[TBL] [Abstract][Full Text] [Related]
38. Immunopotentiation of outer membrane protein through anti-idiotype Pasteurella multocida vaccine in rabbits.
Arif J; Rahman SU; Arshad M; Akhtar P
Biologicals; 2013 Nov; 41(6):339-44. PubMed ID: 23830882
[TBL] [Abstract][Full Text] [Related]
39. Restriction endonuclease analysis using Hhal and Hpall to discriminate among group B Pasteurella multocida associated with haemorrhagic septicaemia.
Rimler RB
J Med Microbiol; 2000 Jan; 49(1):81-87. PubMed ID: 10628829
[TBL] [Abstract][Full Text] [Related]
40. Influence of amino acids and vitamins on the growth of gdhA derivative Pasteurella multocida B:2 for use as an animal vaccine.
Oslan SNH; Tan JS; Saad MZ; Halim M; Mohamed MS; Ariff AB
Bioprocess Biosyst Eng; 2019 Mar; 42(3):355-365. PubMed ID: 30483888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
